Abstract:Objective To investigate the anti-apotoptic effects of calreticulin (CRT) on tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated T cells apoptosis in rheumatoid arthritis (RA).Methods Levels of CRT in the synovial fluid from patients with RA (23 cases) and osteoarthritis (OA) (36 cases) were detected with enzyme-linked immunosorbent assay (ELISA);the expression and localization of CRT in RA and OA synovial tissue were detected by immunohistochemistry.The capacity of CRT binding to TRAIL was measured by ELISA;the effect of TRAIL on Jurkat T cell proliferation was determined by the methylthiazolyl tetrazolium (MTT) assay,CRT on TRAIL-mediated apoptosis by flow cytometry analysis.The t-test and SNK-q test were used for statistical analysis.Results ① CRT were significantly up-regulated both in synovial fluid and tissue from RA than those from OA [(5.6±2.5) ng/ml and (3.2±1.3) ng/rd,t=6.233,P＜0.05;32 787± 18 294 and 7 945±2 765,t=15.662,P＜0.01].② Binding rate of CRT-TRAIL increased to (117±9)％ and (155±14)％ with TRAIL stimulation (1 μg/ml and 2 μg/ml,respectively) compared to the controls (q=3.858,8.647;P＜0.01).③ The proliferation of Jurkat T cell was inhibited after co-cultured with TRAIL,at 12 hours,100ng/ml TRAIL treated cell showed a significant decreased survival rate and at 24 hours (q=7.532,P＜0.05),and the similar results were shown both with 50 ng/ml and 100 ng/ml TRAIL (q=9.211,12.879;P＜0.01).④ T cell early apoptosis was suppressed by the combination of CRT and TRAIL:with CRT (4,8 and 16 ng/ml),the corresponding apoptotic rates were (30.7±1.1)％,(24.5±1.1)％ and (22.3±1.5)％ respectively,which showed significant differences compared with the control group (32.5±1.4)％ (q=3.82,12.17,15.39;P＜0.05).Conclusion Increased levels of CRT are detected in the synovial fluid and tissue in RA;and CRT is expressed in inflammatory cells in synovial tissue from RA patients.In addition,CRT can partly inhibit TRAIL-mediated apoptosis of Jurkat T cells via binding to TRAIL,which may suggest its potential role in the pathogenesis especially in inflammation of RA.

Modulation of cellular immunity by antibodies against calreticulin.

Recombinant Murine Calreticulin Fragment 39-272 Expands Cd1d(Hi)Cd5(+) Il-10-Secreting B Cells That Modulate Experimental Autoimmune Encephalomyelitis in C57bl/6 Mice

Antibody-Secreting Cells under the Stimulation with Calreticulin Fragment ESEARCH ARTICLE R

Functional Analysis of Recombinant Calreticulin Fragment 39-272: Implications for Immunobiological Activities of Calreticulin in Health and Disease

Immunological Activities of Calreticulin

CD1dhiCD5+ B Cells Differentiate into Antibody-Secreting Cells under the Stimulation with Calreticulin Fragment

Aberrant Glycosylation Augments the Immuno-Stimulatory Activities of Soluble Calreticulin.

Self-Oligomerization Is Essential For Enhanced Immunological Activities Of Soluble Recombinant Calreticulin

Immunological Activity Difference Between Native Calreticulin Monomers and Oligomers

Soluble Calreticulin Induces Tumor Necrosis Factor-Α (Tnf-Α) and Interleukin (IL)-6 Production by Macrophages Through Mitogen-Activated Protein Kinase (MAPK) and NFκB Signaling Pathways.

Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen-Specific T Lymphocyte Responses against Melanoma

Calreticulin Fragment 39-272 Promotes B16 Melanoma Malignancy Through Myeloid-Derived Suppressor Cells in Vivo.

Calreticulin is a Microbial-Binding Molecule with Phagocytosis-Enhancing Capacity.

Roles of calreticulin on anti-tumor effection

[Research on Physiological and Pathophysiological Functions of Calreticulin].

In vitro immunoregulatory role of recombinant Ancylostoma ceylanicum calreticulin

The inhibitional effect of calreticulin on turnout necrosis factor-related apoptosis-inducing ligand-mediated T cell apoptosis in rheumatoid arthritis

Membrane Bound CRT Fragment Accelerates Tumor Growth of Melanoma B16 Cell In Vivo through Promoting M2 Polarization via TLR4

Up-regulation of calreticulin expression and its significance in patients with rheumatoid arthritis in vivo

Calreticulin regulates TGF-β1-induced epithelial mesenchymal transition through modulating Smad signaling and calcium signaling.

Calreticulin functions in vitro as a molecular chaperone for both glycosylated and non-glycosylated proteins